Related Experiment Video
Updated: Jun 15, 2026
08:37
Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
Osteopontin expression in cardiomyocytes induces dilated cardiomyopathy
Marie-Ange Renault1, Fanny Robbesyn, Patricia Réant
1INSERM U828, Ave. du Haut Lévêque, Pessac, France.
Circulation. Heart Failure
|March 5, 2010
Summary
Osteopontin (OPN) overexpression in the heart causes chronic myocarditis, leading to dilated cardiomyopathy and heart failure in mice. This suggests OPN is a potential therapeutic target for heart disease.
Area of Science:
- Cardiovascular Research
- Immunology
- Molecular Biology
Background:
- Inflammatory processes are key in myocarditis, dilated cardiomyopathy, and heart failure.
- Osteopontin (OPN) expression is elevated in heart disease, but its role is unclear.
Purpose of the Study:
- To investigate the role of osteopontin (OPN) in the development of heart disease.
Main Methods:
- Generated transgenic mice (MHC-OPN) with cardiac-specific OPN overexpression.
- Conducted electrocardiography, echocardiography, and histological analysis.
- Assessed for autoantibodies in serum.
Main Results:
- MHC-OPN mice exhibited premature death, conduction defects, and left ventricular dysfunction.
- Histology revealed cardiomyocyte loss, fibrosis, and T-cell infiltration with Th1 polarization.
- No autoantibodies against OPN or cardiac proteins were detected.
Conclusions:
- Cardiac OPN expression drives T-cell recruitment and activation, causing chronic myocarditis.
- This leads to myocyte destruction and dilated cardiomyopathy.
- OPN represents a potential therapeutic target for limiting heart failure progression.
Related Concept Videos
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:25Cardiomyopathy I: Introduction and Classification
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...